Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 5—May 2009

Research

Cross-Border Dissemination of Methicillin-Resistant Staphylococcus aureus, Euregio Meuse-Rhin Region

Ruud H. DeurenbergComments to Author , Eric Nulens, Havard Valvatne, Silvie Sebastian, Christel Driessen, Jos Craeghs, Els De Brauwer, Bernhard Heising, Yvette J. Kraat, Joachim Riebe, Frans S. Stals, Thera A. Trienekens, Jacques Scheres, Alexander W. Friedrich, Frank H. Van Tiel, Patrick S. Beisser, and Ellen E. Stobberingh
Author affiliations: University Hospital Maastricht, Maastricht, the Netherlands (R.H. Deurenberg, H. Valvatne, S. Sebastian, C. Driessen, J. Scheres, F.H. van Tiel, P.S. Beisser, E.E. Stobberingh); General Hospital Sint-Jan, Brugge, Belgium (E. Nulens); General Hospital Vesalius, Tongeren, Belgium (J. Craeghs); Atrium Medical Center, Heerlen, the Netherlands (E. De Brauwer); General Hospital Düren, Düren, Germany (B. Heising); Orbis Medical and Care Center, Sittard, the Netherlands (Y.J. Kraat); Laboratory Aachen, Aachen, Germany (J. Riebe); Laurentius Hospital, Roermond, the Netherlands (F.S. Stals); VieCuri Medical Center, Venlo, the Netherlands (T.A. Trienekens); University of Münster, Münster, Germany (A.W. Friedrich)

Main Article

Table 1

Non–β-lactam antimicrobial drug resistance patterns of 257 MRSA isolates in the Euregio Meuse-Rhin region, July 2005–April 2006*

Country No. isolates No. (%) resistant MRSA isolates
CIP MXF CLI GEN CLR SXT TET RIF MUP FUC
Belgium 44 44 (100) 43 (98) 5 (11) 2 (5) 24 (55) 0 4 (9) 0 4 (9) 0
Germany 92 89 (97) 89 (97) 78 (85) 5 (5) 83 (90) 0 3 (3) 2 (2) 1 (1) 1 (1)
The Netherlands 121 84 (69) 79 (65) 76 (63) 11 (9) 93 (77) 3 (2) 22 (18) 0 8 (7) 1 (1)
Total 257 217 (84) 211 (82) 159 (62) 18 (7) 200 (78) 3 (1) 29 (12) 2 (1) 13 (5) 2 (1)

*MRSA, methicillin-resistant Staphylococcus aureus; CIP, ciprofloxacin; MXF, moxifloxacin; CLI, clindamycin; GEN, gentamicin; CLR, clarithromycin; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; RIF, rifampin; MUP, mupirocin; FUC, fucidic acid. No isolates showed resistance to linezolid, vancomycin, or teicoplanin.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO